These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 6694528)
21. Effects of a fluorinated pyrimidinedione anti-cancer drug, 5-fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione (FT), and related compounds on nigro-striatal dopaminergic neurons in the central nervous system. Toide K; Unemi N; Segawa T Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):111-24. PubMed ID: 3925907 [TBL] [Abstract][Full Text] [Related]
22. Effects of systemic and intracerebroventricular domperidone treatment on striatal and hypothalamic dopaminergic neurons. Ferretti C; Benfenati F; Cimino M; Vantini G; Lipartiti M; Muccioli G; di Carlo R; Algeri S Med Biol; 1983; 61(6):331-6. PubMed ID: 6676604 [TBL] [Abstract][Full Text] [Related]
23. Reduced haloperidol: effects on striatal dopamine metabolism and conversion to haloperidol in the rat. Korpi ER; Wyatt RJ Psychopharmacology (Berl); 1984; 83(1):34-7. PubMed ID: 6204352 [TBL] [Abstract][Full Text] [Related]
24. Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride. See RE Neurosci Lett; 1991 Aug; 129(2):265-8. PubMed ID: 1720879 [TBL] [Abstract][Full Text] [Related]
25. Effects of intermittent and continuous haloperidol administration on the dopaminergic system in the rat brain. Kashihara K; Sato M; Fujiwara Y; Harada T; Ogawa T; Otsuki S Biol Psychiatry; 1986 Jun; 21(7):650-6. PubMed ID: 3011131 [TBL] [Abstract][Full Text] [Related]
27. Enhancement of haloperidol-induced increase in rat striatal or mesolimbic 3,4-dihydroxyphenylacetic acid and homovanillic acid by pretreatment with chronic methamphetamine. Toru M; Mataga N; Takashima M; Nishikawa T Psychopharmacology (Berl); 1981; 74(4):316-20. PubMed ID: 6794073 [TBL] [Abstract][Full Text] [Related]
28. Time course of the changes in striatal acetylcholine levels induced by pergolide and haloperidol after lesion of the nigrostriatal dopaminergic pathways in the rat. Fage D; Guerin B; Feuerstein C; Demenge P; Scatton B Brain Res; 1984 Sep; 310(2):379-83. PubMed ID: 6488029 [TBL] [Abstract][Full Text] [Related]
29. Haloperidol: effect of long-term treatment on rat striatal dopamine synthesis and turnover. Lerner P; Nosé P; Gordon EK; Lovenberg W Science; 1977 Jul; 197(4299):181-3. PubMed ID: 17917 [TBL] [Abstract][Full Text] [Related]
30. The use of striatal dopaminergic supersensitivity for the evaluation of drugs with possible antidyskinetic properties. Valchár M; Krejcí I; Kasafírek E; Schuh J; Dlabac A Pol J Pharmacol Pharm; 1985; 37(3):311-5. PubMed ID: 2866500 [TBL] [Abstract][Full Text] [Related]
31. Cyclo(Leu-Gly) has opposite effects on D-2 dopamine receptors in different brain areas. Lee JM; Ritzmann RF; Fields JZ Peptides; 1984; 5(1):7-10. PubMed ID: 6231532 [TBL] [Abstract][Full Text] [Related]
32. Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis. Zetterström T; Sharp T; Ungerstedt U Eur J Pharmacol; 1984 Oct; 106(1):27-37. PubMed ID: 6085051 [TBL] [Abstract][Full Text] [Related]
33. Chronic nicotine use blocks haloperidol-induced increase in striatal D2-dopamine receptor density. Prasad C; Spahn SA; Ikegami H Biochem Biophys Res Commun; 1989 Feb; 159(1):48-52. PubMed ID: 2522303 [TBL] [Abstract][Full Text] [Related]
34. Involvement of striatal dopamine, homovanillic acid and 3,4-dihydroxyphenylacetic acid in the hypothermia and catalepsy induced by haloperidol. Massotti M Pharmacol Res Commun; 1977 Apr; 9(4):381-9. PubMed ID: 559310 [No Abstract] [Full Text] [Related]
35. Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation. Carvey PM; Hitri A; Goetz CG; Tanner CM; Klawans HL Life Sci; 1988; 42(22):2207-15. PubMed ID: 3374255 [TBL] [Abstract][Full Text] [Related]
37. [Effects of anticholinergics and clozapine on the activation of the striatal dopaminergic system in the rat by haloperidol. Neurochemical findings (author's transl)]. Bürki HR; Sayers AC; Ruch W; Asper H Arzneimittelforschung; 1976; 26(6):1094-6. PubMed ID: 989385 [TBL] [Abstract][Full Text] [Related]
38. The effect of melanotrophin release inhibiting factor (MIF) and cyclo (Leu-Gly) on the tolerance to morphine-induced antinociception in the rat: a dose-response study. Bhargava HN Br J Pharmacol; 1981 Apr; 72(4):707-14. PubMed ID: 6116510 [TBL] [Abstract][Full Text] [Related]
39. Tolerance to fluphenazine and supersensitivity to apomorphine in central dopaminergic systems after chronic fluphenazine decanoate treatment. Wheeler SC; Roth RH Naunyn Schmiedebergs Arch Pharmacol; 1980 Jun; 312(2):151-9. PubMed ID: 7190650 [TBL] [Abstract][Full Text] [Related]
40. [Effect of intracaudate administration of kainic acid on the activity of the dopaminergic system]. Zharkovskiĭ AM; Nurk AM Fiziol Zh SSSR Im I M Sechenova; 1981 Nov; 67(11):1606-10. PubMed ID: 6799331 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]